SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63383 357 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
61936I think there are a couple things hurting AADI share price at this point, startidrtom123427/15/2023
61935But AADI’s burn rate is non-trivial and Fyarro is currently only approved for a Olecranon17/14/2023
61934Trading below company's cash in hand, current approved product can generate Karuna1-7/14/2023
61933I pretty much agree with your points. As much as I understand and agree with thjargonweary37/13/2023
61932In terms of AD, the FDA needs to be reformed. Subjecting a 2000+ terminally ill ghettogoulash-7/13/2023
61931Yes, I agree. And as I have posted here before, I do expect Simufilam to be appjargonweary27/12/2023
61930Have no idea what to think when it comes to AUPH !! But sure hope they close soplhky346567/12/2023
61929I understand. But why has FDA granted approval for other drugs that treat AD whplhky346537/12/2023
61928Come to think of it, Cassava Sciences (Pain Therapeutics) was founded 25 years aghettogoulash37/12/2023
61927That's my biggest concern, as well. No pipeline. I hope to god they come thrghettogoulash27/12/2023
61926My concern is not whether Simufilam works or not; I believe that it does work. jargonweary37/12/2023
61925Anybody else think that AUPH deal is going to close soon after MKT’s move ?dorightbythem27/11/2023
61924People keep saying that Simufilam is not working in moderate patients. Let'sghettogoulash-7/11/2023
61923Well, I hope you are right and that it proves to be miraculous. My preference, jargonweary57/11/2023
61922* mainly, not "many"ghettogoulash-7/11/2023
61921The chart is not industry standard because: (1) Except for months 12-18, it ploghettogoulash17/11/2023
61920I didn't know that about you, Jargon. That puts things in perspective about ghettogoulash-7/11/2023
61919Yes, I agree with all that you wrote.jargonweary17/7/2023
61918error on my part for the 55% quote....it was that 55% of those ON blood thinnersscorman117/7/2023
61917Jargon, I particularly agree with your last paragraph, although there’s a case tOlecranon37/7/2023
61916For those who are invested in or follow AADI, are you aware of any change in funOlecranon-7/7/2023
61915Biogen down $10 on a real full approval....quite diff from the $20bill spike froscorman1-7/7/2023
61914Not sure that anyone outside of the FDA itself knows for sure what it is thinkinjargonweary57/7/2023
61913In our randomized withdrawal study that followed a 12-month open-label safety sterippetoe17/7/2023
61912SAVA...this about that: Biogen may have gotten approval, but they only expect 10scorman147/6/2023
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News